Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-16T15:52:19.973Z Has data issue: false hasContentIssue false

Complications and mortality in patients with schizophrenia anddiabetes: Population-based cohort study

Published online by Cambridge University Press:  02 January 2018

Chi-Shin Wu
Affiliation:
Department of Psychiatry, Far Eastern Memorial Hospital, Taipei, Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taipei and Department of Psychiatry, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan
Mei-Shu Lai
Affiliation:
Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taipei, Taiwan
Susan Shur-Fen Gau*
Affiliation:
Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University College of Public Health, Taipei and Department of Psychiatry, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan
*
Susan Shur-Fen Gau, Department of Psychiatry, NationalTaiwan University Hospital & College of Medicine, No. 7, Chung-ShanSouth Road, Taipei 10002, Taiwan. Email: gaushufe@ntu.edu.tw
Rights & Permissions [Opens in a new window]

Abstract

Background

The long-term outcome of patients with both diabetes and schizophrenia remains unclear.

Aims

To explore whether having schizophrenia increases the risk of advanced complications and mortality in people with diabetes.

Method

This is a population-based matched cohort study using Taiwan's National Health Insurance Research Database. A total of 11 247 participants with diabetes and schizophrenia and 11 247 participants with diabetes but not schizophrenia were enrolled. We used Cox proportional hazard models to determine the effect of schizophrenia on macrovascular and microvascular complications, and all-cause mortality.

Results

The adjusted hazard ratios were 1.49 (95% CI 1.32–1.68) for macrovascular complications, 1.05 (95% CI 0.91–1.21) for microvascular complications and 3.68 (95% CI 3.21–4.22) for all-cause mortality in patients with diabetes and schizophrenia compared with those patients with diabetes but not schizophrenia.

Conclusions

Patients with both diabetes and schizophrenia had an increased risk of macrovascular complications and all-cause mortality but did not have statistically significant elevated risk of microvascular complications.

Information

Type
Papers
Copyright
Copyright © Royal College of Psychiatrists, 2015 
Figure 0

Fig. 1Flow chart of selection of study population.LHID, Longitudinal Health Insurance Database; PIMC, Psychiatric Inpatient Medical Claims; NHI, National Health Insurance.

Figure 1

TABLE 1Baseline characteristics of the diabetes+schizophrenia group and the diabetes without schizophrenia (comparison) group

Figure 2

TABLE 2Hazard ratios for macrovascular and microvascular complications, and mortality of the diabetes+schizophrenia group and diabetes without schizophrenia (comparison) group, total and stratified by patient characteristics (n = 22 494)

Figure 3

Fig. 2Kaplan–Meier analysis of risk for (a) macrovascular complications, (b) microvascular complications and (c) all-cause mortality.

Figure 4

TABLE 3Post hoc analysis for the quality of diabetes care in the diabetes+schizophrenia group and the diabetes without schizophrenia (comparison) group (n = 22 494)

Supplementary material: PDF

Wu et al. supplementary material

Supplementary Table S1-S2

Download Wu et al. supplementary material(PDF)
PDF 221.7 KB

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.